Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
Fondazione Italiana Linfomi - ETS
City of Hope Medical Center
University of Nebraska
Universität des Saarlandes
University of Wisconsin, Madison
Royal Marsden NHS Foundation Trust
Ruijin Hospital
University of Miami
Samsung Medical Center
M.D. Anderson Cancer Center
University of Göttingen